Which medication is an antimuscarinic agent used to manage COPD?

• A. Atropine
• B. Ipratropium
• C. Benztropine
• D. Propranolol

Answer: (B)

Ipratropium is an antimuscarinic agent that is commonly used in the management of Chronic Obstructive Pulmonary Disease (COPD). It works by blocking the muscarinic receptors in the airways, leading to bronchodilation. This helps to relieve symptoms such as wheezing, shortness of breath, and coughing associated with COPD. By inhibiting the action of acetylcholine, a neurotransmitter that causes bronchoconstriction, ipratropium promotes relaxation of the bronchial muscles, thus improving airflow and overall respiratory function.

In the context of managing COPD, ipratropium is often administered through inhalation, providing localized effects in the lungs with fewer systemic side effects compared to oral or intravenous forms of medication. Its role in therapy typically involves use as a rescue inhaler or as a part of maintenance therapy.

The other agents mentioned serve different purposes. Atropine, while an antimuscarinic, is used more commonly in emergencies or for other conditions such as bradycardia rather than for actual COPD management. Benztropine is primarily used to treat Parkinson's disease and extrapyramidal symptoms, and propranolol is a non-selective beta-blocker used for cardiovascular conditions, not for respiratory